BP lowering with endovascular baroreflex amplification in resistant hypertension: the CALM-FIM study

BP lowering with endovascular baroreflex amplification in resistant hypertension the CALMFIM study
3' education - Aug. 29, 2017 - Dr. Wilko Spiering - UMCU
  • Overview

    ESC 2017 Dr. Wilko Spiering summarises the results of the CALM-FIM study, showing that endovascular baroreflex amplification with MobiusHD device lowers BP in resistant hypertension.

  • Educational information

    This 3-minute education provides a summary of just presented scientific data, recorded during the ESC 2017 congress. The objective is to provide a brief commentary and potential implications of these findings.

  • Faculty

    Dr. Wilko Spiering - internist, University Medical Center Utrecht, The Netherlands

    Study investigator CALM-FIM study, President of the Dutch Hypertension Society

  • Disclosures

    The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme. PACE-cme did not receive financial support for the production of this 3-minute education.

    Read more about the CALM-FIM study

    The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Facebook Comments


We’re glad to see you’re enjoying PACE-CME…
but how about a more personalized experience?

Register for free